ABN Amro Investment Solutions Has $9.90 Million Position in Colgate-Palmolive Company $CL

ABN Amro Investment Solutions lessened its holdings in shares of Colgate-Palmolive Company (NYSE:CL) by 20.0% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 123,791 shares of the company’s stock after selling 30,871 shares during the period. ABN Amro Investment Solutions’ holdings in Colgate-Palmolive were worth $9,896,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. lifted its holdings in shares of Colgate-Palmolive by 1.2% during the second quarter. Vanguard Group Inc. now owns 82,751,689 shares of the company’s stock worth $7,522,129,000 after buying an additional 993,432 shares during the last quarter. Norges Bank bought a new position in Colgate-Palmolive during the second quarter worth $960,390,000. Diamond Hill Capital Management Inc. raised its stake in Colgate-Palmolive by 46.7% during the 3rd quarter. Diamond Hill Capital Management Inc. now owns 8,077,549 shares of the company’s stock valued at $645,719,000 after purchasing an additional 2,572,796 shares during the last quarter. Invesco Ltd. boosted its holdings in Colgate-Palmolive by 9.1% in the 2nd quarter. Invesco Ltd. now owns 7,489,050 shares of the company’s stock valued at $680,755,000 after purchasing an additional 621,841 shares during the period. Finally, Acadian Asset Management LLC grew its position in Colgate-Palmolive by 42.9% in the 2nd quarter. Acadian Asset Management LLC now owns 6,124,347 shares of the company’s stock worth $556,663,000 after purchasing an additional 1,839,853 shares during the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on the stock. Piper Sandler upped their price objective on shares of Colgate-Palmolive from $88.00 to $96.00 and gave the company an “overweight” rating in a research report on Friday, January 30th. Morgan Stanley upped their price target on Colgate-Palmolive from $87.00 to $100.00 and gave the company an “overweight” rating in a report on Monday, February 2nd. JPMorgan Chase & Co. lifted their price objective on Colgate-Palmolive from $93.00 to $97.00 and gave the stock an “overweight” rating in a report on Monday, February 2nd. Jefferies Financial Group lifted their price target on shares of Colgate-Palmolive from $85.00 to $91.00 and gave the stock a “hold” rating in a research note on Monday, February 2nd. Finally, Rothschild & Co Redburn set a $93.00 price target on shares of Colgate-Palmolive in a report on Friday. Eleven research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $94.38.

More Colgate-Palmolive News

Here are the key news stories impacting Colgate-Palmolive this week:

• Positive Sentiment: Jim Cramer highlighted Colgate’s strong growth on his show, a high-visibility endorsement that can boost investor sentiment and trading interest. Colgate (CL) had great growth, says Jim Cramer
• Positive Sentiment: Zacks Research raised several near‑term and longer‑term EPS estimates (including FY2026, FY2027 and Q4 updates) — a signal of improving analyst expectations that supports the stock’s upside. Market summary with Zacks note: Colgate-Palmolive (CL) — MarketBeat summary
• Positive Sentiment: Recent quarterly results beat estimates (Q4 EPS and revenue topped consensus) and the company recently paid its regular quarterly dividend — both reinforce Colgate’s cash-generation and income-profile that investors prize in staples. Full company/analyst roundup: Colgate-Palmolive (CL) — MarketBeat summary
• Neutral Sentiment: Zacks issued a mix of small raises and cuts across individual quarters (some Q1–Q3 2026/2027 estimates were trimmed while other quarters were nudged higher). The net effect is modest — watch upcoming quarterly cadence rather than reacting to isolated quarter tweaks. Source: MarketBeat/Zacks summary: Colgate-Palmolive (CL) — MarketBeat summary
• Negative Sentiment: Significant insider selling by the COO, Panagiotis Tsourapas — 35,000 shares sold Feb. 11 and another 15,000 on Feb. 12 (disclosures show a large reduction in his holdings). Large exec sales can be perceived negatively by investors even if they’re for diversification or liquidity reasons. Colgate-Palmolive (NYSE:CL) COO Sells $1,467,150.00 in Stock
• Negative Sentiment: Another insider (John Hazlin) recently sold ~20,989 shares; multiple insider sales in a short span increase perceived governance/insider-conviction risk. SEC filing and trade details: SEC Filing — Insider Sales

Colgate-Palmolive Stock Up 0.5%

NYSE CL opened at $96.61 on Friday. Colgate-Palmolive Company has a one year low of $74.54 and a one year high of $100.18. The firm has a market cap of $77.87 billion, a PE ratio of 36.87, a price-to-earnings-growth ratio of 4.36 and a beta of 0.29. The company has a debt-to-equity ratio of 5.90, a current ratio of 0.42 and a quick ratio of 0.27. The stock’s 50 day simple moving average is $83.80 and its 200 day simple moving average is $81.87.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, January 30th. The company reported $0.95 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.91 by $0.04. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.The business had revenue of $5.23 billion during the quarter, compared to analysts’ expectations of $5.13 billion. During the same period in the previous year, the business posted $0.91 earnings per share. The firm’s revenue for the quarter was up 5.8% compared to the same quarter last year. As a group, sell-side analysts forecast that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, February 13th. Stockholders of record on Wednesday, January 21st were given a dividend of $0.52 per share. The ex-dividend date was Wednesday, January 21st. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.2%. Colgate-Palmolive’s payout ratio is presently 79.39%.

Insider Transactions at Colgate-Palmolive

In other news, insider John Hazlin sold 20,989 shares of the stock in a transaction on Tuesday, February 10th. The stock was sold at an average price of $94.25, for a total value of $1,978,213.25. Following the transaction, the insider owned 17,645 shares of the company’s stock, valued at $1,663,041.25. This represents a 54.33% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, COO Panagiotis Tsourapas sold 15,000 shares of Colgate-Palmolive stock in a transaction on Thursday, February 12th. The stock was sold at an average price of $97.81, for a total value of $1,467,150.00. Following the sale, the chief operating officer directly owned 10,415 shares of the company’s stock, valued at approximately $1,018,691.15. This trade represents a 59.02% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 184,683 shares of company stock valued at $17,486,693. 0.34% of the stock is owned by company insiders.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.